Adult Stem Cell Assay Market Report 2026

The adult stem cell assay market size has grown rapidly in recent years. It will grow from $11.93 billion in 2025 to $13.84 billion in 2026 at a compound annual growth rate (CAGR) of 16%. The growth in the historic period can be attributed to expansion of stem cell research programs, increased funding for regenerative medicine, growth in academic and clinical research activities, availability of advanced laboratory instruments, rising collaboration between academia and industry.

The adult stem cell assay market size is expected to see rapid growth in the next few years. It will grow to $24.75 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing clinical translation of stem cell therapies, rising demand for precision medicine research tools, expansion of cell-based drug discovery, growing automation in laboratory workflows, increased regulatory focus on assay validation. Major trends in the forecast period include increasing adoption of high-throughput assay platforms, rising use of multiparametric stem cell analysis, growing demand for regenerative medicine testing, expansion of automated cell sorting technologies, enhanced focus on assay standardization and reproducibility.

The increasing demand for regenerative medicine is anticipated to drive the growth of the adult stem cell assay market in the coming years. Regenerative medicine includes biomedical strategies focused on replacing, repairing, or restoring normal function to human cells, tissues, or organs that have been damaged by aging, disease, injury, or congenital conditions. The expanding global aging population is fueling demand for regenerative medicine due to its potential to address age-related disorders such as arthritis and cardiovascular diseases. Adult stem cell assays are used to assess differentiation into specific cell types, as well as cell proliferation, migration, and interactions, in order to confirm cell viability and effectiveness. These assays play a vital role in the development of safe and effective regenerative therapies, including stem cell-based treatments. For example, in July 2023, according to a report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drug and device data, there were 247 gene therapies in Phase II at the end of Q1 2023, which increased by 5 percent to 260 by the end of Q2. Therefore, the rising demand for regenerative medicine is driving the adult stem cell assay market.

Key companies operating in the adult stem cell assay market are developing advanced, ready-to-use adult stem cell organoid tubule assay models to enhance the predictability of therapeutic outcomes and speed up the development of personalized treatments. A ready-to-use adult stem cell organoid tubule assay model is a preconfigured system that uses organoids derived from adult stem cells and is designed for immediate research application. For instance, in March 2023, MIMETAS, a Netherlands-based provider of organ-on-a-chip disease models, launched the OrganoReady product line. This fully prepared adult stem cell-derived organoid tubule-based assay model eliminates the complexity associated with cell culture and tissue generation, enabling rapid experimentation. The product includes adult stem cell-derived colon and kidney organoid tubules optimized for mechanistic toxicology and drug-induced organ injury studies. With 64 organoids per plate, the platform supports medium- to high-throughput screening, offering a reliable solution for adult stem cell assays.

In January 2024, STEMCELL Technologies Inc., a Canada-based biotechnology company, acquired Propagenix Inc. for an undisclosed amount. This acquisition is intended to strengthen STEMCELL Technologies’ position in the adult stem cell assay market by incorporating Propagenix’s expertise and technologies, thereby supporting the development of advanced research tools and solutions. Propagenix Inc. is a US-based biotechnology company.

Major companies operating in the adult stem cell assay market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Lonza Group AG, Sartorius AG, Sigma Aldrich Chemicals Pvt. Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Abcam Plc, R&D Systems Inc., BioLegend Inc., Sino Biological Inc., Cell Signaling Technology, Inc., Enzo Biochem Inc., Creative Bioarray, ScienCell Research Laboratories Inc., Cell Biolabs Inc., Abnova Corporation, American Type Culture Collection, AMSBIO LLC.

North America was the largest region in the adult stem cell assay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult stem cell assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the adult stem cell assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the adult stem cell assay market by increasing costs of imported laboratory instruments, reagents, assay kits, cell sorting systems, and analytical software platforms. Research institutes and biotech companies in North America and Europe are most affected due to reliance on imported high-end laboratory equipment, while Asia-Pacific faces higher costs for advanced assay technologies. These tariffs are raising research and development expenses and extending procurement timelines. However, they are also supporting local manufacturing of assay consumables, domestic instrument assembly, and regional innovation in cost-optimized stem cell testing solutions.

The adult stem cell assay market research report is one of a series of new reports that provides adult stem cell assay market statistics, including adult stem cell assay industry global market size, regional shares, competitors with a adult stem cell assay market share, detailed adult stem cell assay market segments, market trends and opportunities, and any further data you may need to thrive in the adult stem cell assay industry. This adult stem cell assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An adult stem cell assay is a laboratory test used to examine the behavior and properties of adult stem cells, which are undifferentiated cells with the capacity for self-renewal and differentiation into various tissue-specific cell types. The primary objective of this assay is to evaluate the cells’ regenerative potential, their ability to differentiate, and their effectiveness in therapeutic applications for disease treatment.

The key types of adult stem cell assays include viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, functional assays, and apoptosis. The viability or cytotoxicity segment assesses stem cell health by measuring cell survival and responses under different conditions to determine the effects of potential toxic agents. These assays are applied across multiple areas such as regenerative medicine and therapy development, drug discovery and development, and clinical research, and are utilized by various end users including government research institutes, private research organizations, and industry research entities.

The adult stem cell assay market consists of revenues earned by entities by providing services such as colony-forming unit (CFU) assays, migration and invasion assays, toxicity screening, multipotency assays, gene editing, and genetic manipulation. The market value includes the value of related goods sold by the service provider or included within the service offering. The adult stem cell assay market also includes sales of incubators, centrifuges, microscopes, plate readers, and PCR machines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.